Dr. Raymond Edward Kleinfelder III, DO

Dr. Kleinfelder practices at Metropolis Dermatology in Los Angeles, California.

Dr. Kleinfelder's NPI, 1659751121, was assigned on May 31, 2015. Dr. Kleinfelder graduated from Chicago College of Osteopathic Medicine at Midwestern University in 2015. Dr. Kleinfelder holds Illinois license 036151703.

Dr. Kleinfelder's primary practice is Metropolis Dermatology, at 888 S Figueroa St Suite 1050 Suite 1050, Los Angeles, CA 90017-5310. The practice phone is (213) 319-3339.

Dr. Kleinfelder's primary practice is Metropolis Dermatology in Los Angeles, California. The medical group on file is Metropolis Dermatology. Dmand AI also links Dr. Kleinfelder to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kleinfelder practices. Vendor and product names are available with a free account.

Dermatology is Dr. Kleinfelder's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Kleinfelder is board certified in dermatology by the American Board of Dermatology. Dr. Kleinfelder is licensed in Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and hives among the conditions Dr. Kleinfelder treats.

CMS data shows 5,683 Medicare services from Dr. Kleinfelder across 23 procedure codes in 2024, for 699 Medicare patients. Medicare paid $346,292 for them. Every service was in an office.

CMS counts 699 Medicare patients who saw Dr. Kleinfelder in 2024. The largest group is 75 to 84, with 292 patients. 73% of them have high cholesterol, and 62% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kleinfelder's median patient age at 39, with 50% women.

In 2024, Dr. Kleinfelder wrote 823 Medicare Part D claims for 291 patients. 91% of them were for generic drugs. CMS names the drug for 723 of them, across 20 drugs with 11 or more claims each, at $257,103 in total drug cost. In 2023, CMS named 475 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kleinfelder for performance year 2024, reported as part of a group. Dr. Kleinfelder accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 51 procedures of removal of skin lesions by Dr. Kleinfelder, more than 72% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Kleinfelder, published from 2015 to 2021. 2021 was the busiest year, with 2. Dr. Kleinfelder's most frequent co-authors are Brad P. Glick, MD, Igor A. Altman, DO and Stefanie Cubelli, DO.

CMS Open Payments shows 601 general payments to Dr. Kleinfelder from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $3,089.

Dr. Kleinfelder graduated from Chicago College of Osteopathic Medicine at Midwestern University in 2015. Dr. Kleinfelder is a member of AOA.

Dr. Kleinfelder is in network with 9 carriers, including Aetna, HCSC and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.